Reportlinker Adds Orphan Drugs in Asia 2011

Monday, May 23, 2011 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, May 23, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Orphan

Drugs in Asia 2011

http://www.reportlinker.com/p0510901/Orphan-Drugs-in-Asia-2011.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

While orphan drug laws in Asia

may provide benefits for companies registering new drugs, such as marketing exclusivity, an expedited registration process, and a reduction in the number of clinical trials required, each registration process is unique and can pose a variety of challenges. This report reviews the orphan drug regulations throughout Asia and discusses various business issues related to orphan drugs in Asia. Lists of approved orphan drugs in Asia and orphan drug associations are also included.

To order this report:

Drug and Medication Industry: Orphan Drugs in Asia 2011

Drug and Medication Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Contact Nicolas BombourgReportlinkerEmail: [email protected]US: (805)652-2626Intl: +1 805-652-2626

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook